{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:28:39Z","timestamp":1792985319284,"version":"4.5.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2001,10,23]]},"DOI":"10.1212\/wnl.57.8.1434","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:56:46Z","timestamp":1336917406000},"page":"1434-1440","source":"Crossref","is-referenced-by-count":178,"title":["Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy"],"prefix":"10.1212","volume":"57","author":[{"given":"J. T.","family":"Kissel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. P.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. R.","family":"Mendell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. M.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. C.","family":"Griggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Tawil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the FSH-DY Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","unstructured":"Tawil   R Griggs   RC.   Facioscapulohumeral muscular dystrophy. In:  Rosenberg  RN Pruisiner  SB DiMauro  S Barchi  RL eds.  The molecular and genetic basis of neurological disease.   Boston MA:   Butterworth Heinemann 1997:  931\u2013938."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1040824"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0992-26"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-8966(96)00400-2"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/2.12.2037"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005768-199606000-00005"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1996.81.4.1610"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(98)00084-7"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0830615"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(200004)23:4<521::AID-MUS10>3.0.CO;2-8"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0840651"},{"key":"e_1_3_2_13_2","first-page":"1471","volume":"27","year":"1995","unstructured":"Caruso JF, Signorile JF, Perry AC, et al. The effects of albuterol and isokinetic exercise on the quadriceps muscle group. Med Sci Sports Exerc . 1995; 27: 1471\u20131476.","journal-title":"Med Sci Sports Exerc"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.5.1402"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.3_Part_1.442"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.1.38"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-097X.1991.tb00662.x"},{"key":"e_1_3_2_18_2","first-page":"320.","volume":"36","year":"1994","unstructured":"Tawil R, Herr BE, Moxley RT, et al. Dual-energy absorptiometry: quantifying muscle mass in therapeutic trials. Ann Neurol . 1994; 36: 320.","journal-title":"Ann Neurol"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/ptj\/74.3.253"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1987.tb11211.x"},{"key":"e_1_3_2_21_2","first-page":"93","volume":"41","year":"1996","unstructured":"Newman-Tancredi A, Verriele L, Chaput C, Millan MJ. Down-regulation of rat beta-adrenoceptors by clenbuterol or desipramine does not require chronic treatment: [3H] CGP-12177 binding reveals rapid (24 hour) modulation. Brain Res Bull . 1996; 41: 93\u201396.","journal-title":"Brain Res Bull"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.158.supplement_2.13tac110"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1997.82.2.435"},{"key":"e_1_3_2_24_2","first-page":"734","volume":"80","year":"1996","unstructured":"Dupont-Versteegden EE. Exercise and clenbuterol as strate- gies to decrease the progression of muscular dystrophy in mdx mice. J Appl Physiol . 1996; 80: 734\u2013741.","journal-title":"J Appl Physiol"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1681.1999.03001.x"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.57.8.1434","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T12:06:31Z","timestamp":1711541191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.57.8.1434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10,23]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2001,10,23]]}},"alternative-id":["10.1212\/WNL.57.8.1434"],"URL":"https:\/\/doi.org\/10.1212\/wnl.57.8.1434","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,10,23]]}}}